Calcium silicate bioactive ceramics induce osteogenesis through oncostatin M

Current research emphasizes the role of immune responses in determining the success of bone substitute materials. Macrophages are central to these immune responses and influence both inflammation and bone formation. While it is known that macrophages regulate tissue remodeling, the specific mechanisms through which they modulate osteogenesis remain unclear. Earlier findings suggest that calcium silicate (CS) bioceramics can enhance bone regeneration. However, the precise interaction between CS and macrophage activity has not been fully explored. This gap motivated the investigation of how CS affects macrophage polarization and its downstream impact on osteogenic differentiation. No prior work had resolved how immune-modulating materials could be optimized for bone repair. This uncertainty drove the current study to examine the role of macrophage-derived factors in CS-induced osteogenesis. The study aimed to clarify how CS influences macrophage behavior and whether this behavior translates into improved bone formation.

The aim of this study was to determine how calcium silicate (CS) bioceramics influence macrophage polarization and subsequent osteogenic differentiation of mesenchymal stem cells. The researchers hypothesized that CS could modulate macrophage activity to promote bone formation. They sought to investigate whether macrophage-conditioned medium, influenced by CS, could enhance osteogenesis. The study also aimed to identify the specific signaling pathways involved in this process. By analyzing macrophage behavior under CS stimulation, the researchers intended to uncover the mechanisms linking immune modulation and bone regeneration. This work builds on prior findings that CS bioceramics support osteogenesis but lacks a detailed explanation of the underlying immune interactions. The motivation stems from the need to improve the osteoimmunomodulatory properties of bone substitute materials. The findings could inform the design of biomaterials that better support bone repair through immune regulation.

The study used calcium silicate (CS) bioceramics to stimulate macrophage cultures and monitor changes in their phenotype. Macrophage-conditioned medium was collected after exposure to CS extracts and used to assess its effect on bone marrow mesenchymal stem cells (BMSCs). The researchers evaluated osteogenic differentiation of BMSCs by measuring alkaline phosphatase activity and mineral deposition. They also analyzed macrophage polarization using flow cytometry and gene expression profiling. To determine the role of oncostatin M (OSM), the researchers used neutralizing antibodies and pathway inhibitors. The effects of CS were compared to those of β-tricalcium phosphate (β-TCP) in an in vivo model of femoral bone defects. The study combined in vitro cell culture experiments with in vivo animal testing to validate findings. The methodology focused on linking macrophage behavior to downstream osteogenic outcomes.

Exposure to CS extracts caused macrophages to polarize toward an M2 phenotype, characterized by anti-inflammatory markers. Macrophage-conditioned medium pretreated with CS extracts significantly enhanced osteogenic differentiation of BMSCs. This effect was confirmed through increased alkaline phosphatase activity and mineralized nodule formation. The study identified oncostatin M (OSM) as a key factor in this process. OSM promoted osteogenesis through activation of the ERK1/2 and JAK3 signaling pathways. Neutralizing OSM reduced the osteogenic potential of the conditioned medium, confirming its role. In vivo experiments showed that CS implants outperformed β-TCP in promoting new bone formation at femoral defect sites. These findings support the hypothesis that CS modulates macrophage activity to enhance osteogenesis.

The authors concluded that calcium silicate (CS) bioceramics induce macrophage polarization toward an M2 phenotype. This polarization is associated with enhanced osteogenic differentiation of BMSCs. The study demonstrated that oncostatin M (OSM) is a critical mediator of this effect. OSM activates the ERK1/2 and JAK3 pathways to promote osteogenesis. In vivo results confirmed that CS implants stimulate new bone formation more effectively than β-TCP. These findings suggest that immune modulation by CS is a key mechanism in its osteogenic activity. The authors propose that CS’s ability to modulate macrophage behavior contributes to its effectiveness as a bone substitute. These conclusions align with the study’s aim to clarify how CS influences osteogenesis through immune interactions.